Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency

Institute for Human Genetics Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA Division of Pulmonary and Sleep Medicine Clinical Research Institute of the Children's Hospital of Wisconsin, Milwaukee, WI, USA Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA Division of Genetics, Children's Hospital of Wisconsin, Milwaukee, WI, USA Channing Laboratory, Brigham and Women's Hospital, Boston, MA, USA Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas, USA The Human and Molecular Genetics Center, The Medical College of Wisconsin, Milwaukee, WI, USA Department of Epidemiology and Biostatistics, University of California, San Francisco, USA Division of Research, Kaiser, Oakland, CA, USA.
Clinical Genetics (Impact Factor: 3.65). 10/2011; 82(6). DOI: 10.1111/j.1399-0004.2011.01804.x
Source: PubMed

ABSTRACT Sebro R, Levy H, Schneck K, Dimmock D, Raby BA, Cannon CL, Broeckel U, Risch NJ. Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency. Cystic fibrosis (CF) is a monogenetic disease with a complex phenotype. Over 1500 mutations in the CFTR gene have been identified; however, the p.F508del mutation is most common. There has been limited correlation between the CFTR mutation genotype and the disease phenotypes. We evaluated the non-p.F508del mutation of 108 p.F508del compound heterozygotes using the biological classification method, Grantham and Sorting Intolerant from Tolerant (SIFT) scores to assess whether these scoring systems correlated with sweat chloride levels, pancreatic sufficiency, predicted FEV(1), and risk of infection with Pseudomonas aeruginosa in the last year. Mutations predicted to be 'mild' by the biological classification method are associated with more normal sweat chloride levels (p < 0.001), pancreatic sufficiency (p < 0.001) and decreased risk of infection with Pseudomonas in the last year (p = 0.014). Lower Grantham scores are associated with more normal sweat chloride levels (p < 0.001), and pancreatic sufficiency (p = 0.014). Higher SIFT scores are associated with more normal sweat chloride levels (p < 0.001) and pancreatic sufficiency (p = 0.011). There was no association between pulmonary function measured by predicted FEV(1) and the biological classification (p = 0.98), Grantham (p = 0.28) or SIFT scores (p = 0.62), which suggests the pulmonary disease related to CF may involve other modifier genes and environmental factors.


Available from: Carolyn Louise Cannon, Jan 15, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In term newborns meconium ileus is frequently associated with cystic fibrosis. Reports on meconium ileus in preterm infants being diagnosed with cystic fibrosis early after birth are very scarce. Associations between genotype and phenotype in cystic fibrosis and its particular comorbidities have been reported. Two extremely preterm twin infants (26 weeks of gestation) born from a Malaysian mother and a Caucasian father were presented with typical signs of meconium ileus. Despite immediate surgery both displayed a unique and finally lethal course. Mutation analysis revealed a novel, probably pathogenic cystic fibrosis mutation, p.Cys524Tyr. The novel mutation might explain the severity of disease next to typical sequelae of prematurity. Preterm neonates with meconium ileus have to be evaluated for cystic fibrosis beyond ethnical boundaries, but may take devastating clinical courses despite early treatment. The novel, potentially pathogenic CF mutation p.Cys524Tyr might be associated with severe meconium ileus in neonates. Disease-modifying loci are important targets for intestinal comorbidity of cystic fibrosis.
    BMC Pediatrics 01/2014; 14(1):13. DOI:10.1186/1471-2431-14-13 · 1.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The extent to which sweat chloride concentration predicts survival and clinical phenotype independently of CFTR genotype in cystic fibrosis is not well understood. We analyzed the US Cystic Fibrosis Foundation Patient Registry data using Cox regression to examine the relationship between sweat chloride concentration (<60, 60-<80, ≥80mmol/L), CFTR genotype (high and lower risk for lung function decline), and survival and mixed linear regression to examine the relationship between sweat chloride, CFTR genotype, and measures of lung function and growth. When included in the same model, CFTR genotype, but not sweat chloride, was independently associated with survival and with lung function, height, and BMI. Among patients with unclassified CFTR genotype, sweat chloride was an independent predictor of survival (<60 HR 0.53 [0.37, 0.77], 60-<80 0.51 [0.42, 0.63]). Sweat chloride concentration may be a useful predictor of mortality and clinical phenotype when CFTR genotype functional class is unclassified. Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
    Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society 02/2015; DOI:10.1016/j.jcf.2015.01.005 · 3.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several extra-pulmonary disorders have been linked to cigarette smoking; however, the mechanisms underlying involvement of organs not directly exposed to smoke remain unknown. Smoking is reported to cause CFTR dysfunction in the airway, and is also associated with pancreatitis, male infertility, and cachexia, features characteristic of CF and suggestive of an etiological role for CFTR. Demographics, spirometry, exercise tolerance, symptom questionnaires, CFTR genetics and sweat chloride analysis were obtained in smokers with and without COPD. CFTR activity was measured by nasal potential difference in mice and by Ussing chamber electrophysiology in vitro. Serum acrolein levels were estimated with mass spectroscopy. Healthy smokers (29.45 +/- 13.90 mEq), COPD smokers (31.89 +/- 13.9) and COPD former smokers (25.07 +/- 10.92) had elevated sweat chloride levels compared to normal controls (14.5 +/- 7.77) indicating reduced CFTR activity in a non-respiratory organ. Intestinal current measurements also demonstrated a 65% decrease in CFTR function in smokers compared to never smokers. CFTR activity was decreased by 68% in normal HBE cells exposed to plasma from smokers, suggesting a one or more circulating agents could confer CFTR dysfunction. Cigarette smoke exposed mice had decreased CFTR activity in intestinal epithelium (84.3% and 45%, after 5 and 17 weeks, respectively). Acrolein, a component of cigarette smoke, was higher in smokers, blocked CFTR by inhibiting channel gating, and was attenuated by antioxidant N-acetylcysteine, a known scavenger of acrolein. Smoking causes systemic CFTR dysfunction. Acrolein present in cigarette smoke mediates CFTR defects in extra-pulmonary tissues in smokers.
    American Journal of Respiratory and Critical Care Medicine 09/2013; 188(11). DOI:10.1164/rccm.201304-0733OC · 11.99 Impact Factor